8-K item 3.01
Exchange deficiency notices
Open Nasdaq and NYSE listing deficiency notices and their cure deadlines as stated in the filing.
Open notices by deadline 4
| Company | Rule | Notice | Cure by | Filing |
|---|---|---|---|---|
| Roman DBDR Acquisition Corp. II | Too few public holdersNasdaq rule 5450(a)(2) | Aug 19, 2026 | Feb 15, 2027 | 8-K item 3.01 |
| Rising Dragon Acquisition | Market value too lowNasdaq rule 5550(b)(2) | Aug 20, 2026 (8-K filed) | Feb 16, 2027 | 8-K item 3.01 |
| Aimei Health Technology | Market value too lowNasdaq rule 5450(b)(2)(A) | Aug 25, 2026 (8-K filed) | Feb 17, 2027 | 8-K item 3.01 |
| Innventure | Stock under $1Nasdaq rule 5450(a)(1) | Oct 23, 2026 (8-K filed) | Apr 21, 2027 | 8-K item 3.01 |
Data through Nov 5, 2026, the newest 8-K item 3.01 SEC Tracker has read.
Dates and rules are as stated in each 8-K item 3.01 filing; a blank means the filing did not state one. Read the filing for the full terms. Not investment advice. Not affiliated with the U.S. SEC. Listing deadlines on the calendar · All screens